In older adults, an AS01E-adjuvanted RSVPreF3 OA vaccine reduced RSV-related lower respiratory tract disease
- PMID: 37276600
- DOI: 10.7326/J23-0038
In older adults, an AS01E-adjuvanted RSVPreF3 OA vaccine reduced RSV-related lower respiratory tract disease
Erratum in
-
Corrections to ACP Journal Club: Errors in Clinical Impact Ratings.Ann Intern Med. 2023 Dec;176(12):JC144. doi: 10.7326/J23-0087. Epub 2023 Oct 3. Ann Intern Med. 2023. PMID: 37782926 No abstract available.
Abstract
Papi A, Ison MG, Langley JM, et al; AReSVi-006 Study Group. Respiratory syncytial virus prefusion F protein vaccine in older adults. N Engl J Med. 2023;388:595-608. 36791160.
Conflict of interest statement
Comment on
-
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604. N Engl J Med. 2023. PMID: 36791160 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical